Funded Tech Companies
Gemin X Pharmaceuticals
Gemin X Pharmaceuticals, operating out of Malvern, was acquired by Cephalon.
Company Overview
Company Name
Gemin X Pharmaceuticals
Company Status
Acquired or Merged
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
400 Chesterfield Parkway 100
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Company Background Information
Overview
Gemin X Pharmaceuticals Inc. specializes in the discovery and development of novel small-molecule cancer therapeutics based on the regulation of apoptosis, the body's natural ability to destroy injured or damaged cells.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/21/2011
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Dolan
Chief Financial Officer
Michael Dixon
Chief Medical Officer
Jean Viallet
Chief Scientific Officer
Gordon Shore
Vice President
Mark Berger
VP - Bus. Development
Art Fratamico
VP - Operations
Edwina Wyatt-Knowles
Company Investors
- Valence Life Sciences (Eric Roberts)
- Sanderling Ventures (Robert McNeil)
- HBM Healthcare Investments
- Merlin BioMed Group
- ProQuest Investments
- Pinnacle Ventures
- Solidarity Fund QFL
- SBNY
- H.I.G. Capital (Aaron Davidson)
- Canadian Medical Discoveries Fund
Browse more funded tech companies:
Gemie | Gemini Sports Analytics
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs